ACTIVE SUBSTANCE / INN

INSULIN DEGLUDEC

Brand name(s): RYZODEG 70/30, Tresiba, TRESIBA, XULTOPHY 100/3.6
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
BLA203314
BLA208583
ACTIVE SUBSTANCE
Insulin Degludec
REGULATORS
FDA · EMA
SPONSORS / MAH
Novo Nordisk A/S, NOVO
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TRESIBABLA203314NOVOPrescription
XULTOPHY 100/3.6BLA208583NOVOPrescription
RYZODEG 70/30BLA203313NOVODiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TresibaNovo Nordisk A/SAuthorised20/01/2013Diabetes Mellitus

FULL INTELLIGENCE ON INSULIN DEGLUDEC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →